If You’ve Been Harmed by Plavix, We May be able to Help

Norfolk, Newport News, and Roanoke, Virginia

Plavix is a prescription blood thinner designed to prevent strokes and heart attacks. Although Plavix was initially marketed in part as a safer alternative to aspirin, increasing evidence suggests that the drug actually increases the risk for stroke and heart attack as well as contributes to other medical problems in some patients. Other side-effects linked to Plavix include:

  • Chest pain
  • Increased risk of gastrointestinal bleeding and ulcers
  • Lowered blood pressure
  • Passing or vomiting blood
  • Thrombotic thrombocytopenic purpura (a rare disorder that causes clots to form in blood vessels)

Bristol-Myers Squibb and Sanofi-Aventis, the makers and distributors of Plavix, are currently facing a number of lawsuits alleging that the companies rushed the drug to market without adequate testing, without proper warning as to potential risks, and using false marketing claims to sell Plavix. Food and Drug Administration (FDA) warnings regarding Plavix date back to 1998, just a year after the FDA approved the drug, which is also known as clopidogrel. In 2010, the FDA issued a so-called “black box warning” for Plavix; black box warnings appear on the packaging for prescription medication that have the potential to cause severe adverse effects. Drug manufacturers have an obligation to consumers to properly test their products and provide users with detailed information regarding possible side-effects. The Virginia defective product attorneys at Kalfus & Nachman have more than three decades of experience holding negligent companies accountable for the harm their products cause. If you were harmed or a loved one suffered wrongful death from taking Plavix, please contact the product liability attorneys at Kalfus & Nachman. We proudly represent clients in the Roanoke, Newport News, Portsmouth and Norfolk, Virginia, areas.

This entry was posted on Tuesday, November 22nd, 2011 at 03:57 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed. Entries (RSS) | Comments (RSS).